Nov 21, 2019 - Merck's (MRK) Keytruda gets approval in Europe to treat first-line head/neck cancer based on data from the phase III KEYNOTE-048 study.
Nov 20, 2019 - Does Incyte (INCY) have what it takes to be a top stock pick for momentum investors? Let's find out.
Nov 19, 2019 - We highlight a few principal players from the biotech sector, which are likely to witness a winning run in the near term.
Nov 05, 2019 - Incyte (INCY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Oct 29, 2019 - Incyte Corporation's (NASDAQ:INCY) Q3 2019 Results Earnings Conference Call October 29, 2019, 08:00 AM ET Company Participants Michael Booth - Divisional Vice President of Investor Relations and Corpo
Oct 29, 2019 - INCY earnings call for the period ending September 30, 2019.
Oct 29, 2019 - Incyte (INCY) reports better-than-expected results for the third quarter of 2019, owing to strong Jakafi sales.
Oct 28, 2019 - Four drug/biotech stocks are scheduled to release third-quarter results on Oct 29. Let's see how these companies are placed before their earnings call.
Oct 28, 2019 - Sanofi's (SNY) Specialty Care and Vaccines units are likely to have driven third- quarter earnings.
Oct 25, 2019 - AbbVie's (ABBV) Q3 sales may have been weighed down by biosimilar competition for Humira in international markets. However, strong growth of oncology drugs might have offset impact of Humira's international sales erosion.